431 related articles for article (PubMed ID: 28133653)
1. Personalized protein corona on nanoparticles and its clinical implications.
Corbo C; Molinaro R; Tabatabaei M; Farokhzad OC; Mahmoudi M
Biomater Sci; 2017 Feb; 5(3):378-387. PubMed ID: 28133653
[TBL] [Abstract][Full Text] [Related]
2. Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles.
García Vence M; Chantada-Vázquez MDP; Vázquez-Estévez S; Manuel Cameselle-Teijeiro J; Bravo SB; Núñez C
Clin Chim Acta; 2020 Feb; 501():102-111. PubMed ID: 31678275
[TBL] [Abstract][Full Text] [Related]
3. Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake.
Pustulka SM; Ling K; Pish SL; Champion JA
ACS Appl Mater Interfaces; 2020 Oct; 12(43):48284-48295. PubMed ID: 33054178
[TBL] [Abstract][Full Text] [Related]
4. Understanding the nanoparticle-protein corona complexes using computational and experimental methods.
Kharazian B; Hadipour NL; Ejtehadi MR
Int J Biochem Cell Biol; 2016 Jun; 75():162-74. PubMed ID: 26873405
[TBL] [Abstract][Full Text] [Related]
5. Analysis of hard protein corona composition on selective iron oxide nanoparticles by MALDI-TOF mass spectrometry: identification and amplification of a hidden mastitis biomarker in milk proteome.
Magro M; Zaccarin M; Miotto G; Da Dalt L; Baratella D; Fariselli P; Gabai G; Vianello F
Anal Bioanal Chem; 2018 May; 410(12):2949-2959. PubMed ID: 29532191
[TBL] [Abstract][Full Text] [Related]
6. Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles.
Francia V; Yang K; Deville S; Reker-Smit C; Nelissen I; Salvati A
ACS Nano; 2019 Oct; 13(10):11107-11121. PubMed ID: 31525954
[TBL] [Abstract][Full Text] [Related]
7. Identification of main influencing factors on the protein corona composition of PLGA and PLA nanoparticles.
Spreen H; Behrens M; Mulac D; Humpf HU; Langer K
Eur J Pharm Biopharm; 2021 Jun; 163():212-222. PubMed ID: 33862242
[TBL] [Abstract][Full Text] [Related]
8. A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona.
Hadjidemetriou M; Al-Ahmady Z; Buggio M; Swift J; Kostarelos K
Biomaterials; 2019 Jan; 188():118-129. PubMed ID: 30343255
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Chemical Nature of Nanoparticle-Protein Interactions.
Baimanov D; Cai R; Chen C
Bioconjug Chem; 2019 Jul; 30(7):1923-1937. PubMed ID: 31259537
[TBL] [Abstract][Full Text] [Related]
10. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
11. Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood.
Ju Y; Kelly HG; Dagley LF; Reynaldi A; Schlub TE; Spall SK; Bell CA; Cui J; Mitchell AJ; Lin Z; Wheatley AK; Thurecht KJ; Davenport MP; Webb AI; Caruso F; Kent SJ
ACS Nano; 2020 Nov; 14(11):15723-15737. PubMed ID: 33112593
[TBL] [Abstract][Full Text] [Related]
12. Formation and biological effects of protein corona for food-related nanoparticles.
Cui G; Su W; Tan M
Compr Rev Food Sci Food Saf; 2022 Mar; 21(2):2002-2031. PubMed ID: 34716644
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles-cell association predicted by protein corona fingerprints.
Palchetti S; Digiacomo L; Pozzi D; Peruzzi G; Micarelli E; Mahmoudi M; Caracciolo G
Nanoscale; 2016 Jul; 8(25):12755-63. PubMed ID: 27279572
[TBL] [Abstract][Full Text] [Related]
14. Proteomic and Lipidomic Analysis of Nanoparticle Corona upon Contact with Lung Surfactant Reveals Differences in Protein, but Not Lipid Composition.
Raesch SS; Tenzer S; Storck W; Rurainski A; Selzer D; Ruge CA; Perez-Gil J; Schaefer UF; Lehr CM
ACS Nano; 2015 Dec; 9(12):11872-85. PubMed ID: 26575243
[TBL] [Abstract][Full Text] [Related]
15. Differential Recognition of Nanoparticle Protein Corona and Modified Low-Density Lipoprotein by Macrophage Receptor with Collagenous Structure.
Lara S; Perez-Potti A; Herda LM; Adumeau L; Dawson KA; Yan Y
ACS Nano; 2018 May; 12(5):4930-4937. PubMed ID: 29668255
[TBL] [Abstract][Full Text] [Related]
16. Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns.
Lai W; Wang Q; Li L; Hu Z; Chen J; Fang Q
Colloids Surf B Biointerfaces; 2017 Apr; 152():317-325. PubMed ID: 28131092
[TBL] [Abstract][Full Text] [Related]
17. Precision Nanomedicine Development Based on Specific Opsonization of Human Cancer Patient-Personalized Protein Coronas.
Ren J; Cai R; Wang J; Daniyal M; Baimanov D; Liu Y; Yin D; Liu Y; Miao Q; Zhao Y; Chen C
Nano Lett; 2019 Jul; 19(7):4692-4701. PubMed ID: 31244235
[TBL] [Abstract][Full Text] [Related]
18. Plasma proteins facilitates placental transfer of polystyrene particles.
Gruber MM; Hirschmugl B; Berger N; Holter M; Radulović S; Leitinger G; Liesinger L; Berghold A; Roblegg E; Birner-Gruenberger R; Bjelic-Radisic V; Wadsack C
J Nanobiotechnology; 2020 Sep; 18(1):128. PubMed ID: 32907583
[TBL] [Abstract][Full Text] [Related]
19. Isolation Methods Influence the Protein Corona Composition on Gold-Coated Iron Oxide Nanoparticles.
Hoang KNL; Wheeler KE; Murphy CJ
Anal Chem; 2022 Mar; 94(11):4737-4746. PubMed ID: 35258278
[TBL] [Abstract][Full Text] [Related]
20. Protein corona: Opportunities and challenges.
Zanganeh S; Spitler R; Erfanzadeh M; Alkilany AM; Mahmoudi M
Int J Biochem Cell Biol; 2016 Jun; 75():143-7. PubMed ID: 26783938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
